BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7788887)

  • 1. Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes.
    Marian AJ; Yu QT; Mann DL; Graham FL; Roberts R
    Circ Res; 1995 Jul; 77(1):98-106. PubMed ID: 7788887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility.
    Marian AJ; Zhao G; Seta Y; Roberts R; Yu QT
    Circ Res; 1997 Jul; 81(1):76-85. PubMed ID: 9201030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo short-term expression of a hypertrophic cardiomyopathy mutation in adult rabbit myocardium: myofibrillar incorporation without early disarray.
    Yu Q; Zhao G; Marian AJ
    Proc Assoc Am Physicians; 1999; 111(1):45-56. PubMed ID: 9893156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.
    Marian AJ; Roberts R
    Ann Med; 1998 Aug; 30 Suppl 1():24-32. PubMed ID: 9800880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly.
    Becker KD; Gottshall KR; Hickey R; Perriard JC; Chien KR
    J Cell Biol; 1997 Apr; 137(1):131-40. PubMed ID: 9105042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible triggers for hypertrophic cardiomyopathy are established in the early postnatal period.
    Cannon L; Yu ZY; Marciniec T; Waardenberg AJ; Iismaa SE; Nikolova-Krstevski V; Neist E; Ohanian M; Qiu MR; Rainer S; Harvey RP; Feneley MP; Graham RM; Fatkin D
    J Am Coll Cardiol; 2015 Feb; 65(6):560-9. PubMed ID: 25677315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins.
    Rust EM; Albayya FP; Metzger JM
    J Clin Invest; 1999 May; 103(10):1459-67. PubMed ID: 10330428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy.
    Perryman MB; Yu QT; Marian AJ; Mares A; Czernuszewicz G; Ifegwu J; Hill R; Roberts R
    J Clin Invest; 1992 Jul; 90(1):271-7. PubMed ID: 1634614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy.
    Kai H; Muraishi A; Sugiu Y; Nishi H; Seki Y; Kuwahara F; Kimura A; Kato H; Imaizumi T
    Circ Res; 1998 Sep; 83(6):594-601. PubMed ID: 9742054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-independent negative inotropy by beta-myosin heavy chain gene transfer in cardiac myocytes.
    Herron TJ; Vandenboom R; Fomicheva E; Mundada L; Edwards T; Metzger JM
    Circ Res; 2007 Apr; 100(8):1182-90. PubMed ID: 17363698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COOH-terminal truncated human cardiac MyBP-C alters myosin filament organization.
    Sébillon P; Bonne G; Flavigny J; Venin S; Rouche A; Fiszman M; Vikstrom K; Leinwand L; Carrier L; Schwartz K
    C R Acad Sci III; 2001 Mar; 324(3):251-60. PubMed ID: 11291312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
    Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
    Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene transfer, expression, and sarcomeric incorporation of a headless myosin molecule in cardiac myocytes: evidence for a reserve in myofilament motor function.
    Vandenboom R; Herron T; Favre E; Albayya FP; Metzger JM
    Am J Physiol Heart Circ Physiol; 2011 Feb; 300(2):H574-82. PubMed ID: 21112946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy.
    Cheng TH; Shih NL; Chen CH; Lin H; Liu JC; Chao HH; Liou JY; Chen YL; Tsai HW; Chen YS; Cheng CF; Chen JJ
    J Biomed Sci; 2005; 12(1):123-33. PubMed ID: 15864745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes.
    Monteiro da Rocha A; Guerrero-Serna G; Helms A; Luzod C; Mironov S; Russell M; Jalife J; Day SM; Smith GD; Herron TJ
    J Mol Cell Cardiol; 2016 Oct; 99():197-206. PubMed ID: 27620334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
    Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
    J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations.
    Marian AJ; Mares A; Kelly DP; Yu QT; Abchee AB; Hill R; Roberts R
    Eur Heart J; 1995 Mar; 16(3):368-76. PubMed ID: 7789380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy.
    Abchee A; Marian AJ
    J Investig Med; 1997 Apr; 45(4):191-6. PubMed ID: 9154300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation and assembly of myosin in hypertrophic cardiomyopathy with the 403 Arg to Gln beta-myosin heavy chain mutation.
    Vybiral T; Deitiker PR; Roberts R; Epstein HF
    Circ Res; 1992 Dec; 71(6):1404-9. PubMed ID: 1423936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.
    Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R
    J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.